Covered recipient · General Payments record
BRIAN J NGUYEN
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2020–2024
$847.78
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $506.47 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $238.45 | 10 |
| NEW WORLD MEDICAL,INC. | $104.93 | 1 |
| Thea Pharma Inc. | $39.41 | 2 |
| Dompe US, Inc. | $34.66 | 1 |
| Alcon Laboratories Inc | $29.75 | 1 |
| Tarsus Pharmaceuticals, Inc. | $25.10 | 1 |
| RxSight Inc | $20.27 | 1 |
| Amgen Inc. | $13.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.09 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105117112 | CMS |
| ABBVIE INC. | $21.46 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105117114 | CMS |
| ABBVIE INC. | $33.60 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105117116 | CMS |
| ABBVIE INC. | $25.67 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105117118 | CMS |
| ABBVIE INC. | $30.13 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105117120 | CMS |
| ABBVIE INC. | $27.77 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105117122 | CMS |
| ABBVIE INC. | $27.77 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105117124 | CMS |
| ABBVIE INC. | $6.50 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105117126 | CMS |
| ABBVIE INC. | $33.01 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105117128 | CMS |
| ABBVIE INC. | $3.45 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105117130 | CMS |
| Alcon Vision LLC | $29.75 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110723016 | CMS |
| Amgen Inc. | $13.90 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111661873 | CMS |
| Dompe US, Inc. | $34.66 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151398904 | CMS |
| NEW WORLD MEDICAL,INC. | $104.93 | 06/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137398225 | CMS |
| RxSight Inc | $20.27 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144223322 | CMS |
| Tarsus Pharmaceuticals, Inc. | $25.10 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139120370 | CMS |
| Thea Pharma Inc. | $18.71 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074543503 | CMS |
| Thea Pharma Inc. | $20.70 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074543505 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.